Humana Inc. (NYSE:HUM – Get Free Report) declared a quarterly dividend on Tuesday, September 1st. Stockholders of record on Friday, October 30th will be given a dividend of 0.885 per share by the insurance provider on Friday, November 27th. This represents a c) dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, October 30th.
Humana has increased its dividend payment by an average of 0.1%per year over the last three years. Humana has a payout ratio of 24.1% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Humana to earn $15.26 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 23.2%.
Humana Price Performance
Shares of Humana stock opened at $400.12 on Thursday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm has a fifty day simple moving average of $387.50 and a 200-day simple moving average of $293.70. The stock has a market capitalization of $48.05 billion, a price-to-earnings ratio of 37.85, a PEG ratio of 2.59 and a beta of 0.74. Humana has a 1-year low of $163.11 and a 1-year high of $428.88.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Read More
- Five stocks we like better than Humana
- Enova’s Earnings Surge Meets a Valuation Test
- SLB’s Kelvion Deal Could Change How Investors Value the Oilfield Giant
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
